Fri 10/19/2018 02:26 ET
DJIA25379.45327.231.27%TELCO167.640.740.44%GOLD1231.501.350.11%Shanghai2485.990.500.02%
S&P 5002768.7839.871.44%BANKS447.488.411.88%OIL68.950.300.44%BITCOIN6466.4221.990.34%
NASDAQ7485.14154.192.06%PHARM581.584.540.78%US/EU1.170.000.26%Futures2783.2511.130.40%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - Wall Street Pit (Sage Therapeutics Inc. - SAGE)    Stock Due Diligence for All

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SAGE
  
From: blacksheep (Rep: 331) reply to singhtelecomDate: 12/07/2017 07:43
Forum: Wall Street Pit - Msg #2705290 - List SAGE msgs Thread #673943721 (Rec: 0)
Re: Quite a wise investment
Sage Therapeutics' SAGE-217 successful in mid-stage MDD study; shares ahead 52% premarket

Dec. 7, 2017 7:18 AM ET|About: Sage Therapeutics (SAGE)|By: Douglas W. House, SA News Editor
Sage Therapeutics (NASDAQ:SAGE) is up 52% premarket on light volume in response to its announcement of positive results from a Phase 2 clinical trial assessing SAGE-217 for the treatment of adult patients with moderate-to-severe major depressive disorder (MDD), a Fast Track indication in the U.S.

The 89-subject study met its primary endpoint of a statistically significant average reduction in HAM-D score from baseline to day 15 (p<0.0001) versus placebo. HAM-D is a rating scale for depression. At day 15, 64% of patients in the treatment group achieved remission compared to 23% for placebo (p=0.0005). Other secondary endpoints were also met.

SAGE-217 was generally well-tolerated with no serious or severe adverse events observed. The most common adverse events were headache, dizziness, nausea and drowsiness.

Management will host a conference call this morning at 8:00 am ET to discuss the results.

SAGE-217, a neuroactive steroid, is next-generation GABA modulator. The GABA system, the major inhibitory signaling pathway in the brain and central nervous system (CNS), plays a key role in regulating CNS function. The company intends to advance the program into Phase 3 development.


someone bought in the money 1000 calls NOV 75 at 18 bucks



Reply to singhtelecom - Msg #56 - 08/04/2017 10:27

someone bought in the money 1000 calls NOV 75 at 18 bucks
What would you like to do? Message: Endorse | Bookmark | Report AbuseUser blacksheep: Reward | Watch | IgnoreSAGE: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add SAGE
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.